All details for Patel Chem Specialities IPO: Dates, price, subscription, financials, objectives, KPIs, registrar, and company overview.
Price Band: ₹82–84 | Allotment July 30 | Listing August 1, 2025
Patel Chem Specialities IPO: At a Glance
IPO Timeline
| IPO Activity | Date |
|---|---|
| IPO Open Date | July 25, 2025 |
| IPO Close Date | July 29, 2025 |
| Tentative Allotment | July 30, 2025 |
| Refunds Initiation | July 31, 2025 |
| Credit of Shares to Demat | July 31, 2025 |
| IPO Listing Date | August 1, 2025 |
Anchor Investors
| Bid Date | Shares Offered | Anchor Portion Size (₹ Cr) | Lock-in (50%) | Lock-in (90%) |
|---|---|---|---|---|
| July 24, 2025 | 19,87,200 | 16.69 | Aug 29, 2025 | Oct 28, 2025 |
IPO Price & Lot Size
| Price Band | ₹82–84 per share |
|---|---|
| Market Lot | 1,600 Shares |
| Retail Min | 2 lots (3,200 shares) – ₹2,68,800 |
| Retail Max | 2 lots (3,200 shares) – ₹2,68,800 |
| S-HNI Min | 3 lots (4,800 shares) – ₹4,03,200 |
| S-HNI Max | 7 lots (11,200 shares) – ₹9,40,800 |
| B-HNI Min | 8 lots (12,800 shares) – ₹10,75,200 |
Company Financials (₹ Crore)
Bar Chart: Revenue, PAT & Net Worth
Line Chart: Revenue, PAT & Net Worth
| Period Ended | Assets | Revenue | Profit After Tax | EBITDA | Net Worth | Reserves & Surplus | Total Borrowing |
|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 65.31 | 105.55 | 10.57 | 15.80 | 35.40 | 17.53 | 14.85 |
| 31 Mar 2024 | 46.97 | 82.72 | 7.66 | 12.02 | 19.52 | 18.52 | 15.46 |
| 31 Mar 2023 | 37.08 | 69.75 | 2.89 | 5.83 | 11.87 | 10.87 | 11.79 |
Key Performance Indicators (KPI)
| KPI | Values |
|---|---|
| Market Cap | ₹208.91 Cr |
| ROE | 29.85% |
| ROCE | 36.26% |
| Debt/Equity | 0.42 |
| RoNW | 24.32% |
| PAT Margin | 10.01% |
| EBITDA Margin | 14.97% |
| Price to Book Value | 4.11 |
| EPS (Pre IPO) | 5.91 |
| EPS (Post IPO) | 4.25 |
| P/E (Pre IPO) | 14.21 |
| P/E (Post IPO) | 19.77 |
Objects of the Issue
| S.No. | Objects | Expected Amount (₹ Million) |
|---|---|---|
| 1 | Funding capital expenditure requirement of the Company | 431.48 |
| 2 | General corporate purposes | — |
About Patel Chem Specialities Ltd.
Incorporated: 2008
Business: Manufacturer and exporter of pharmaceutical excipients and specialty chemicals.
Products:
- Rheollose® (Sodium Carboxymethyl Cellulose): cellulose gum, thickener, stabilizer
- Disolwell® (Croscarmellose Sodium): super disintegrant for oral pharma formulations
- Swellcal® (Calcium Carboxymethyl Cellulose): super disintegrant, pharma
- AmyloTab™ (Pregelatinized Starch): disintegration/dissolution aid in tablets
Certifications: US-DMF, GMP, international standards.
Clients: Global presence: East Asia, Europe, Middle East, North America, Southeast Asia.
Employees: 136 (Mar 31, 2025)
Promoters: Bhupesh Patel, Anshu Patel, Vini Patel
Strengths:
- Strict quality control, certified manufacturing
- Strong R&D and production capacity
- Diversified product portfolio and global client base
- Financially stable business model
- Experienced promoters and management
Contact Details
Plot No. 272/4-5, Phase II, G.I.D.C Industrial Estate, Vatva Road,
Ahmedabad, Gujarat, 382445
Phone: 91-9712999854
Email: cs@patelchem.com
Website: https://patelchem.com/
Frequently Asked Questions (FAQ)
The price band for Patel Chem Specialities IPO is ₹82–84 per share, as announced in the Red Herring Prospectus (RHP).
The IPO will open for subscription on July 25, 2025, and close on July 29, 2025, as per the announced timeline.
The minimum investment for retail investors is 2 lots (3,200 shares) at ₹2,68,800, based on the upper price band of ₹84 per share.
You can apply for the IPO through:
- Your bank's net banking platform (ASBA facility)
- Brokerage accounts (online or offline)
- Registered investment platforms
- Designated branches of syndicate banks
Refer to the RHP for detailed application instructions.
Patel Chem Specialities Ltd. manufactures and exports pharmaceutical excipients and specialty chemicals. Their revenue sources include:
- Sale of products like Rheollose® (Sodium Carboxymethyl Cellulose), Disolwell® (Croscarmellose Sodium), Swellcal® (Calcium Carboxymethyl Cellulose), and AmyloTab™ (Pregelatinized Starch)
- Export markets in East Asia, Europe, Middle East, North America, and Southeast Asia
- Contract manufacturing and customized solutions
The company focuses on high-quality production with a global client base.
Key risks to consider include:
- Market risk: Dependence on global pharmaceutical markets
- Regulatory risks: Compliance with international standards (e.g., US-DMF, GMP)
- Raw material risks: Fluctuations in raw material prices
- Competition: Intense competition in the pharmaceutical excipients industry
- Economic risks: Sensitivity to global economic conditions
Investors should review the risk factors in the RHP before investing.
As per the RHP, the net proceeds will be used for:
- Funding capital expenditure requirements (₹431.48 million)
- General corporate purposes
Specific allocations will be detailed in the final prospectus.
Patel Chem Specialities has:
- Production facilities in Vatva, Ahmedabad, and Talod, Himmatnagar with 7,200 MT/year capacity
- Revenue growth from ₹69.75 Cr (FY23) to ₹105.55 Cr (FY25)
- PAT growth from ₹2.89 Cr (FY23) to ₹10.57 Cr (FY25)
- Global presence in multiple regions with 136 employees as of March 31, 2025
- Certified manufacturing with US-DMF and GMP standards
The company has a strong track record of consistent growth and quality production.
As of March 31, 2025:
- Total borrowings: ₹14.85 crore
- Debt-to-equity ratio: 0.42
- Interest coverage ratio: Not explicitly stated but supported by strong EBITDA of ₹15.80 Cr
The company maintains a low debt-to-equity ratio, indicating financial stability.
The book running lead manager for Patel Chem Specialities IPO is:
- Globalworth Securities Limited (also the market maker)
They manage the IPO process, including price discovery and share allocation.
